APO Research
Talk to an analyst

APO RESEARCH · REPORT

Point-of-Care Testing (POCT)

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Selected research

Market Structure

Global Point-of-Care Testing (POCT) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025193 pages

Choose your research edition.

Industry ResearchPoint-of-Care Testing (POCT) Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Point-of-Care Testing (POCT) Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Point-of-Care Testing (POCT) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Point-of-Care Testing (POCT) Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Point-of-Care Testing (POCT) Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Global Point-of-Care Testing (POCT) main players are Roche, Abbott, Johnson & Johnson, etc. Global top three manufacturers hold a share over 45%. North America is the largest market, with a share nearly 40%.

This report provides an overview of the global Point-of-Care Testing (POCT) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Point-of-Care Testing (POCT) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Point-of-Care Testing (POCT) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Point-of-Care Testing (POCT) market size, projected growth trends, production technologies, key applications, and end-use industries.

Point-of-Care Testing (POCT) Segment by Company

Roche

Abbott

Johnson & Johnson

Siemens Healthcare

Danaher

Ascensia

Bio-Rad Laboratories

BioMerieux

ARKRAY

Nova Biomedical

Trividia Health

Quidel

Accriva

OraSure Technologies

Helena Laboratories

A. Menarini Diagnostics

Abaxis (Zoetis)

Ortho Clinical Diagnostics

Phamatech

Chembio Diagnostics

Trinity Biotech

ELITech Group

Response Biomedical

Princeton BioMeditech

Alfa Wassermann

Point-of-Care Testing (POCT) Segment by Type

Blood Glucose Testing

Infectious Diseases Testing

Cardiac Markers Testing

Coagulation Testing

Pregnancy and Fertility Testing

Blood Gas/Electrolytes Testing

Urinalysis Testing

Point-of-Care Testing (POCT) Segment by Application

Clinics

Hospitals

Laboratory

Others

Point-of-Care Testing (POCT) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-of-Care Testing (POCT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Point-of-Care Testing (POCT) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-of-Care Testing (POCT).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Point-of-Care Testing (POCT) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Point-of-Care Testing (POCT) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Point-of-Care Testing (POCT) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Point-of-Care Testing (POCT) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Point-of-Care Testing (POCT) Industry Trends Table 2. Point-of-Care Testing (POCT) Industry Drivers Table 3. Point-of-Care Testing (POCT) Industry Opportunities and Challenges Table 4. Point-of-Care Testing (POCT) Industry Restraints Table 5. Global Point-of-Care Testing (POCT) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Point-of-Care Testing (POCT) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Point-of-Care Testing (POCT) Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Point-of-Care Testing (POCT) Sales Market Share by Manufacturers Table 9. Global Point-of-Care Testing (POCT) Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Point-of-Care Testing (POCT) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Point-of-Care Testing (POCT) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Point-of-Care Testing (POCT) Manufacturers, Product Type & Application Table 13. Global Point-of-Care Testing (POCT) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Point-of-Care Testing (POCT) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Blood Glucose Testing Table 17. Major Manufacturers of Infectious Diseases Testing Table 18. Major Manufacturers of Cardiac Markers Testing Table 19. Major Manufacturers of Coagulation Testing Table 20. Major Manufacturers of Pregnancy and Fertility Testing Table 21. Major Manufacturers of Blood Gas/Electrolytes Testing Table 22. Major Manufacturers of Urinalysis Testing Table 23. Global Point-of-Care Testing (POCT) Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 24. Global Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (M Units) Table 25. Global Point-of-Care Testing (POCT) Sales by Type (2027-2032) & (M Units) Table 26. Global Point-of-Care Testing (POCT) Sales Market Share by Type (2021-2026) Table 27. Global Point-of-Care Testing (POCT) Sales Market Share by Type (2027-2032) Table 28. Global Point-of-Care Testing (POCT) Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 29. Global Point-of-Care Testing (POCT) Revenue by Type (2021-2026) & (M Units) Table 30. Global Point-of-Care Testing (POCT) Revenue by Type (2027-2032) & (M Units) Table 31. Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2021-2026) Table 32. Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Clinics Table 34. Major Manufacturers of Hospitals Table 35. Major Manufacturers of Laboratory Table 36. Major Manufacturers of Others Table 37. Global Point-of-Care Testing (POCT) Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 38. Global Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (M Units) Table 39. Global Point-of-Care Testing (POCT) Sales by Application (2027-2032) & (M Units) Table 40. Global Point-of-Care Testing (POCT) Sales Market Share by Application (2021-2026) Table 41. Global Point-of-Care Testing (POCT) Sales Market Share by Application (2027-2032) Table 42. Global Point-of-Care Testing (POCT) Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 43. Global Point-of-Care Testing (POCT) Revenue by Application (2021-2026) & (M Units) Table 44. Global Point-of-Care Testing (POCT) Revenue by Application (2027-2032) & (M Units) Table 45. Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2021-2026) Table 46. Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2027-2032) Table 47. Global Point-of-Care Testing (POCT) Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 48. Global Point-of-Care Testing (POCT) Sales by Region (2021-2026) & (M Units) Table 49. Global Point-of-Care Testing (POCT) Sales Market Share by Region (2021-2026) Table 50. Global Point-of-Care Testing (POCT) Sales Forecasted by Region (2027-2032) & (M Units) Table 51. Global Point-of-Care Testing (POCT) Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Point-of-Care Testing (POCT) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 53. North America Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 54. North America Point-of-Care Testing (POCT) Sales by Country (2027-2032) & (M Units) Table 55. Europe Point-of-Care Testing (POCT) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. Europe Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 57. Europe Point-of-Care Testing (POCT) Sales by Country (2027-2032) & (M Units) Table 58. Asia Pacific Point-of-Care Testing (POCT) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 59. Asia Pacific Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 60. Asia Pacific Point-of-Care Testing (POCT) Sales by Country (2027-2032) & (M Units) Table 61. South America, Middle East and Africa Point-of-Care Testing (POCT) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 62. South America, Middle East and Africa Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 63. South America, Middle East and Africa Point-of-Care Testing (POCT) Sales by Country (2027-2032) & (M Units) Table 64. Global Point-of-Care Testing (POCT) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Point-of-Care Testing (POCT) Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Point-of-Care Testing (POCT) Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Point-of-Care Testing (POCT) Revenue Market Share by Region (2021-2026) Table 68. Global Point-of-Care Testing (POCT) Revenue Market Share by Region (2027-2032) Table 69. Roche Company Information Table 70. Roche Business Overview Table 71. Roche Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Roche Point-of-Care Testing (POCT) Product Portfolio Table 73. Roche Recent Development Table 74. Abbott Company Information Table 75. Abbott Business Overview Table 76. Abbott Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Abbott Point-of-Care Testing (POCT) Product Portfolio Table 78. Abbott Recent Development Table 79. Johnson & Johnson Company Information Table 80. Johnson & Johnson Business Overview Table 81. Johnson & Johnson Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio Table 83. Johnson & Johnson Recent Development Table 84. Siemens Healthcare Company Information Table 85. Siemens Healthcare Business Overview Table 86. Siemens Healthcare Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio Table 88. Siemens Healthcare Recent Development Table 89. Danaher Company Information Table 90. Danaher Business Overview Table 91. Danaher Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Danaher Point-of-Care Testing (POCT) Product Portfolio Table 93. Danaher Recent Development Table 94. Ascensia Company Information Table 95. Ascensia Business Overview Table 96. Ascensia Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Ascensia Point-of-Care Testing (POCT) Product Portfolio Table 98. Ascensia Recent Development Table 99. Bio-Rad Laboratories Company Information Table 100. Bio-Rad Laboratories Business Overview Table 101. Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio Table 103. Bio-Rad Laboratories Recent Development Table 104. BioMerieux Company Information Table 105. BioMerieux Business Overview Table 106. BioMerieux Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. BioMerieux Point-of-Care Testing (POCT) Product Portfolio Table 108. BioMerieux Recent Development Table 109. ARKRAY Company Information Table 110. ARKRAY Business Overview Table 111. ARKRAY Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. ARKRAY Point-of-Care Testing (POCT) Product Portfolio Table 113. ARKRAY Recent Development Table 114. Nova Biomedical Company Information Table 115. Nova Biomedical Business Overview Table 116. Nova Biomedical Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio Table 118. Nova Biomedical Recent Development Table 119. Trividia Health Company Information Table 120. Trividia Health Business Overview Table 121. Trividia Health Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Trividia Health Point-of-Care Testing (POCT) Product Portfolio Table 123. Trividia Health Recent Development Table 124. Quidel Company Information Table 125. Quidel Business Overview Table 126. Quidel Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Quidel Point-of-Care Testing (POCT) Product Portfolio Table 128. Quidel Recent Development Table 129. Accriva Company Information Table 130. Accriva Business Overview Table 131. Accriva Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Accriva Point-of-Care Testing (POCT) Product Portfolio Table 133. Accriva Recent Development Table 134. OraSure Technologies Company Information Table 135. OraSure Technologies Business Overview Table 136. OraSure Technologies Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio Table 138. OraSure Technologies Recent Development Table 139. Helena Laboratories Company Information Table 140. Helena Laboratories Business Overview Table 141. Helena Laboratories Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio Table 143. Helena Laboratories Recent Development Table 144. A. Menarini Diagnostics Company Information Table 145. A. Menarini Diagnostics Business Overview Table 146. A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio Table 148. A. Menarini Diagnostics Recent Development Table 149. Abaxis (Zoetis) Company Information Table 150. Abaxis (Zoetis) Business Overview Table 151. Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio Table 153. Abaxis (Zoetis) Recent Development Table 154. Ortho Clinical Diagnostics Company Information Table 155. Ortho Clinical Diagnostics Business Overview Table 156. Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio Table 158. Ortho Clinical Diagnostics Recent Development Table 159. Phamatech Company Information Table 160. Phamatech Business Overview Table 161. Phamatech Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. Phamatech Point-of-Care Testing (POCT) Product Portfolio Table 163. Phamatech Recent Development Table 164. Chembio Diagnostics Company Information Table 165. Chembio Diagnostics Business Overview Table 166. Chembio Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 167. Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio Table 168. Chembio Diagnostics Recent Development Table 169. Trinity Biotech Company Information Table 170. Trinity Biotech Business Overview Table 171. Trinity Biotech Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 172. Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio Table 173. Trinity Biotech Recent Development Table 174. ELITech Group Company Information Table 175. ELITech Group Business Overview Table 176. ELITech Group Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 177. ELITech Group Point-of-Care Testing (POCT) Product Portfolio Table 178. ELITech Group Recent Development Table 179. Response Biomedical Company Information Table 180. Response Biomedical Business Overview Table 181. Response Biomedical Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 182. Response Biomedical Point-of-Care Testing (POCT) Product Portfolio Table 183. Response Biomedical Recent Development Table 184. Princeton BioMeditech Company Information Table 185. Princeton BioMeditech Business Overview Table 186. Princeton BioMeditech Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 187. Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio Table 188. Princeton BioMeditech Recent Development Table 189. Alfa Wassermann Company Information Table 190. Alfa Wassermann Business Overview Table 191. Alfa Wassermann Point-of-Care Testing (POCT) Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 192. Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio Table 193. Alfa Wassermann Recent Development Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Point-of-Care Testing (POCT) Distributors List Table 197. Point-of-Care Testing (POCT) Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Point-of-Care Testing (POCT) Product Image Figure 2. Global Point-of-Care Testing (POCT) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Point-of-Care Testing (POCT) Market Size (2021-2032) & (US$ Million) Figure 4. Global Point-of-Care Testing (POCT) Sales (2021-2032) & (M Units) Figure 5. Global Point-of-Care Testing (POCT) Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Point-of-Care Testing (POCT) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Blood Glucose Testing Image Figure 9. Infectious Diseases Testing Image Figure 10. Cardiac Markers Testing Image Figure 11. Coagulation Testing Image Figure 12. Pregnancy and Fertility Testing Image Figure 13. Blood Gas/Electrolytes Testing Image Figure 14. Urinalysis Testing Image Figure 15. Global Point-of-Care Testing (POCT) Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 16. Global Point-of-Care Testing (POCT) Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Point-of-Care Testing (POCT) Sales Market Share by Type (2021-2032) Figure 18. Global Point-of-Care Testing (POCT) Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 19. Global Point-of-Care Testing (POCT) Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2021-2032) Figure 21. Clinics Image Figure 22. Hospitals Image Figure 23. Laboratory Image Figure 24. Others Image Figure 25. Global Point-of-Care Testing (POCT) Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 26. Global Point-of-Care Testing (POCT) Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Point-of-Care Testing (POCT) Sales Market Share by Application (2021-2032) Figure 28. Global Point-of-Care Testing (POCT) Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 29. Global Point-of-Care Testing (POCT) Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2021-2032) Figure 31. North America Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 32. North America Point-of-Care Testing (POCT) Sales Market Share by Country (2021-2032) Figure 33. U.S. Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 34. Canada Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 35. Mexico Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 36. Europe Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Europe Point-of-Care Testing (POCT) Sales Market Share by Country (2021-2032) Figure 38. Germany Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 39. France Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 40. U.K. Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 41. Italy Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 42. Netherlands Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 43. Asia Pacific Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 44. Asia Pacific Point-of-Care Testing (POCT) Sales Market Share by Country (2021-2032) Figure 45. China Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 46. Japan Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 47. South Korea Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 48. Southeast Asia Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 49. India Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 50. Australia Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 51. South America, Middle East and Africa Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 52. South America, Middle East and Africa Point-of-Care Testing (POCT) Sales Market Share by Country (2021-2032) Figure 53. Brazil Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 54. South Africa Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 55. Saudi Arabia Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 56. Turkey Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 57. Argentina Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 58. UAE Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 59. Egypt Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 60. Chile Point-of-Care Testing (POCT) Sales and Growth Rate (2021-2032) & (M Units) Figure 61. Global Point-of-Care Testing (POCT) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Point-of-Care Testing (POCT) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Figure 64. North America Point-of-Care Testing (POCT) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Figure 66. Europe Point-of-Care Testing (POCT) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Point-of-Care Testing (POCT) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Point-of-Care Testing (POCT) Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Point-of-Care Testing (POCT) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Point-of-Care Testing (POCT) Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Point-of-Care Testing (POCT) Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Glucose Testing
  • Infectious Diseases Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • Pregnancy and Fertility Testing
  • Blood Gas/Electrolytes Testing
  • Urinalysis Testing
Applications
  • Clinics
  • Hospitals
  • Laboratory
  • Others
Companies covered
  • Roche
  • Abbott
  • Johnson & Johnson
  • Siemens Healthcare
  • Danaher
  • Ascensia
  • Bio-Rad Laboratories
  • BioMerieux
  • ARKRAY
  • Nova Biomedical
  • Trividia Health
  • Quidel
  • Accriva
  • OraSure Technologies
  • Helena Laboratories
  • A. Menarini Diagnostics
  • Abaxis (Zoetis)
  • Ortho Clinical Diagnostics
  • Phamatech
  • Chembio Diagnostics
  • Trinity Biotech
  • ELITech Group
  • Response Biomedical
  • Princeton BioMeditech
  • Alfa Wassermann

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Point-of-Care Testing (POCT) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Point-of-Care Testing (POCT) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Point-of-Care Testing (POCT) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Point-of-Care Testing (POCT) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Point-of-Care Testing (POCT) Market Dynamics
  1. 2.1 Point-of-Care Testing (POCT) Industry Trends
  2. 2.2 Point-of-Care Testing (POCT) Industry Drivers
  3. 2.3 Point-of-Care Testing (POCT) Industry Opportunities and Challenges
  4. 2.4 Point-of-Care Testing (POCT) Industry Restraints
3 Point-of-Care Testing (POCT) Market by Manufacturers
  1. 3.1 Global Point-of-Care Testing (POCT) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Point-of-Care Testing (POCT) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Point-of-Care Testing (POCT) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Point-of-Care Testing (POCT) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Point-of-Care Testing (POCT) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Point-of-Care Testing (POCT) Manufacturers, Product Type & Application
  7. 3.7 Global Point-of-Care Testing (POCT) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Point-of-Care Testing (POCT) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Point-of-Care Testing (POCT) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Point-of-Care Testing (POCT) Tier 1, Tier 2, and Tier 3
4 Point-of-Care Testing (POCT) Market by Type
  1. 4.1 Point-of-Care Testing (POCT) Type Introduction
  2. 4.1.1 Blood Glucose Testing
  3. 4.1.2 Infectious Diseases Testing
  4. 4.1.3 Cardiac Markers Testing
  5. 4.1.4 Coagulation Testing
  6. 4.1.5 Pregnancy and Fertility Testing
  7. 4.1.6 Blood Gas/Electrolytes Testing
  8. 4.1.7 Urinalysis Testing
  9. 4.2 Global Point-of-Care Testing (POCT) Sales by Type
  10. 4.2.1 Global Point-of-Care Testing (POCT) Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Point-of-Care Testing (POCT) Sales by Type (2021-2032)
  12. 4.2.3 Global Point-of-Care Testing (POCT) Sales Market Share by Type (2021-2032)
  13. 4.3 Global Point-of-Care Testing (POCT) Revenue by Type
  14. 4.3.1 Global Point-of-Care Testing (POCT) Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Point-of-Care Testing (POCT) Revenue by Type (2021-2032)
  16. 4.3.3 Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2021-2032)
5 Point-of-Care Testing (POCT) Market by Application
  1. 5.1 Point-of-Care Testing (POCT) Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Laboratory
  5. 5.1.4 Others
  6. 5.2 Global Point-of-Care Testing (POCT) Sales by Application
  7. 5.2.1 Global Point-of-Care Testing (POCT) Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Point-of-Care Testing (POCT) Sales by Application (2021-2032)
  9. 5.2.3 Global Point-of-Care Testing (POCT) Sales Market Share by Application (2021-2032)
  10. 5.3 Global Point-of-Care Testing (POCT) Revenue by Application
  11. 5.3.1 Global Point-of-Care Testing (POCT) Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Point-of-Care Testing (POCT) Revenue by Application (2021-2032)
  13. 5.3.3 Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2021-2032)
6 Global Point-of-Care Testing (POCT) Sales by Region
  1. 6.1 Global Point-of-Care Testing (POCT) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Point-of-Care Testing (POCT) Sales by Region (2021-2032)
  3. 6.2.1 Global Point-of-Care Testing (POCT) Sales by Region (2021-2026)
  4. 6.2.2 Global Point-of-Care Testing (POCT) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Point-of-Care Testing (POCT) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Point-of-Care Testing (POCT) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Point-of-Care Testing (POCT) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Point-of-Care Testing (POCT) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Point-of-Care Testing (POCT) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Point-of-Care Testing (POCT) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Point-of-Care Testing (POCT) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Point-of-Care Testing (POCT) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Point-of-Care Testing (POCT) Revenue by Region
  1. 7.1 Global Point-of-Care Testing (POCT) Revenue by Region
  2. 7.1.1 Global Point-of-Care Testing (POCT) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Point-of-Care Testing (POCT) Revenue by Region (2021-2026)
  4. 7.1.3 Global Point-of-Care Testing (POCT) Revenue by Region (2027-2032)
  5. 7.1.4 Global Point-of-Care Testing (POCT) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Point-of-Care Testing (POCT) Revenue (2021-2032)
  8. 7.2.2 North America Point-of-Care Testing (POCT) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Point-of-Care Testing (POCT) Revenue (2021-2032)
  11. 7.3.2 Europe Point-of-Care Testing (POCT) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Point-of-Care Testing (POCT) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Point-of-Care Testing (POCT) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Point-of-Care Testing (POCT) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Point-of-Care Testing (POCT) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche Point-of-Care Testing (POCT) Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Abbott
  8. 8.2.1 Abbott Company Information
  9. 8.2.2 Abbott Business Overview
  10. 8.2.3 Abbott Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Abbott Point-of-Care Testing (POCT) Product Portfolio
  12. 8.2.5 Abbott Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Siemens Healthcare
  20. 8.4.1 Siemens Healthcare Company Information
  21. 8.4.2 Siemens Healthcare Business Overview
  22. 8.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio
  24. 8.4.5 Siemens Healthcare Recent Developments
  25. 8.5 Danaher
  26. 8.5.1 Danaher Company Information
  27. 8.5.2 Danaher Business Overview
  28. 8.5.3 Danaher Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Danaher Point-of-Care Testing (POCT) Product Portfolio
  30. 8.5.5 Danaher Recent Developments
  31. 8.6 Ascensia
  32. 8.6.1 Ascensia Company Information
  33. 8.6.2 Ascensia Business Overview
  34. 8.6.3 Ascensia Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ascensia Point-of-Care Testing (POCT) Product Portfolio
  36. 8.6.5 Ascensia Recent Developments
  37. 8.7 Bio-Rad Laboratories
  38. 8.7.1 Bio-Rad Laboratories Company Information
  39. 8.7.2 Bio-Rad Laboratories Business Overview
  40. 8.7.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio
  42. 8.7.5 Bio-Rad Laboratories Recent Developments
  43. 8.8 BioMerieux
  44. 8.8.1 BioMerieux Company Information
  45. 8.8.2 BioMerieux Business Overview
  46. 8.8.3 BioMerieux Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BioMerieux Point-of-Care Testing (POCT) Product Portfolio
  48. 8.8.5 BioMerieux Recent Developments
  49. 8.9 ARKRAY
  50. 8.9.1 ARKRAY Company Information
  51. 8.9.2 ARKRAY Business Overview
  52. 8.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ARKRAY Point-of-Care Testing (POCT) Product Portfolio
  54. 8.9.5 ARKRAY Recent Developments
  55. 8.10 Nova Biomedical
  56. 8.10.1 Nova Biomedical Company Information
  57. 8.10.2 Nova Biomedical Business Overview
  58. 8.10.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio
  60. 8.10.5 Nova Biomedical Recent Developments
  61. 8.11 Trividia Health
  62. 8.11.1 Trividia Health Company Information
  63. 8.11.2 Trividia Health Business Overview
  64. 8.11.3 Trividia Health Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Trividia Health Point-of-Care Testing (POCT) Product Portfolio
  66. 8.11.5 Trividia Health Recent Developments
  67. 8.12 Quidel
  68. 8.12.1 Quidel Company Information
  69. 8.12.2 Quidel Business Overview
  70. 8.12.3 Quidel Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Quidel Point-of-Care Testing (POCT) Product Portfolio
  72. 8.12.5 Quidel Recent Developments
  73. 8.13 Accriva
  74. 8.13.1 Accriva Company Information
  75. 8.13.2 Accriva Business Overview
  76. 8.13.3 Accriva Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Accriva Point-of-Care Testing (POCT) Product Portfolio
  78. 8.13.5 Accriva Recent Developments
  79. 8.14 OraSure Technologies
  80. 8.14.1 OraSure Technologies Company Information
  81. 8.14.2 OraSure Technologies Business Overview
  82. 8.14.3 OraSure Technologies Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio
  84. 8.14.5 OraSure Technologies Recent Developments
  85. 8.15 Helena Laboratories
  86. 8.15.1 Helena Laboratories Company Information
  87. 8.15.2 Helena Laboratories Business Overview
  88. 8.15.3 Helena Laboratories Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio
  90. 8.15.5 Helena Laboratories Recent Developments
  91. 8.16 A. Menarini Diagnostics
  92. 8.16.1 A. Menarini Diagnostics Company Information
  93. 8.16.2 A. Menarini Diagnostics Business Overview
  94. 8.16.3 A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio
  96. 8.16.5 A. Menarini Diagnostics Recent Developments
  97. 8.17 Abaxis (Zoetis)
  98. 8.17.1 Abaxis (Zoetis) Company Information
  99. 8.17.2 Abaxis (Zoetis) Business Overview
  100. 8.17.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio
  102. 8.17.5 Abaxis (Zoetis) Recent Developments
  103. 8.18 Ortho Clinical Diagnostics
  104. 8.18.1 Ortho Clinical Diagnostics Company Information
  105. 8.18.2 Ortho Clinical Diagnostics Business Overview
  106. 8.18.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio
  108. 8.18.5 Ortho Clinical Diagnostics Recent Developments
  109. 8.19 Phamatech
  110. 8.19.1 Phamatech Company Information
  111. 8.19.2 Phamatech Business Overview
  112. 8.19.3 Phamatech Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Phamatech Point-of-Care Testing (POCT) Product Portfolio
  114. 8.19.5 Phamatech Recent Developments
  115. 8.20 Chembio Diagnostics
  116. 8.20.1 Chembio Diagnostics Company Information
  117. 8.20.2 Chembio Diagnostics Business Overview
  118. 8.20.3 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio
  120. 8.20.5 Chembio Diagnostics Recent Developments
  121. 8.21 Trinity Biotech
  122. 8.21.1 Trinity Biotech Company Information
  123. 8.21.2 Trinity Biotech Business Overview
  124. 8.21.3 Trinity Biotech Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio
  126. 8.21.5 Trinity Biotech Recent Developments
  127. 8.22 ELITech Group
  128. 8.22.1 ELITech Group Company Information
  129. 8.22.2 ELITech Group Business Overview
  130. 8.22.3 ELITech Group Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 ELITech Group Point-of-Care Testing (POCT) Product Portfolio
  132. 8.22.5 ELITech Group Recent Developments
  133. 8.23 Response Biomedical
  134. 8.23.1 Response Biomedical Company Information
  135. 8.23.2 Response Biomedical Business Overview
  136. 8.23.3 Response Biomedical Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Response Biomedical Point-of-Care Testing (POCT) Product Portfolio
  138. 8.23.5 Response Biomedical Recent Developments
  139. 8.24 Princeton BioMeditech
  140. 8.24.1 Princeton BioMeditech Company Information
  141. 8.24.2 Princeton BioMeditech Business Overview
  142. 8.24.3 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio
  144. 8.24.5 Princeton BioMeditech Recent Developments
  145. 8.25 Alfa Wassermann
  146. 8.25.1 Alfa Wassermann Company Information
  147. 8.25.2 Alfa Wassermann Business Overview
  148. 8.25.3 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio
  150. 8.25.5 Alfa Wassermann Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Point-of-Care Testing (POCT) Value Chain Analysis
  2. 9.1.1 Point-of-Care Testing (POCT) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Point-of-Care Testing (POCT) Production Mode & Process
  6. 9.2 Point-of-Care Testing (POCT) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Point-of-Care Testing (POCT) Distributors
  9. 9.2.3 Point-of-Care Testing (POCT) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst